LITFULO

Indicated For

severe alopecia areata

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get LITFULO (ritlecitinib) at Low or No Cost LITFULO (ritlecitinib) is a prescription medication used to treat severe alopecia areata in adults and adolescents 12 years and older. The **Pfizer Patient Assistance Program** provides eligible patients with free access to LITFULO if they meet specific financial and insurance criteria, primarily targeting uninsured or underinsured individuals who cannot afford their medication[1][2][3]. ## About LITFULO (ritlecitinib) **LITFULO** is an oral kinase inhibitor that helps regrow hair in patients with severe **alopecia areata**, an autoimmune condition causing patchy hair loss. It works by blocking certain enzymes involved in the immune response that attacks hair follicles. Approved by the FDA, it's taken once daily and requires a prescription from a licensed U.S. healthcare provider. Common side effects may include headaches, diarrhea, acne, rashes, and infections—always discuss risks with your doctor. This program ensures access for those facing high costs, as LITFULO can be expensive without assistance[2][10]. ## Who Qualifies for the Program? To qualify for free LITFULO through the Pfizer Patient Assistance Program, you must: - Be 18 years or older (or meet adolescent criteria for LITFULO). - Reside in the U.S. or a U.S. territory with a valid U.S. address (proof of citizenship not required)[3][8]. - Have a valid prescription for LITFULO from a U.S.-licensed healthcare provider for outpatient treatment[1][3]. - Have an FDA-approved diagnosis, such as severe alopecia areata[2][10]. - Lack commercial insurance or have insufficient coverage (e.g., denied by insurer after appeal)[3][8]. - Meet income eligibility, typically up to **500% of the Federal Poverty Level (FPL)**, though exact household size thresholds are not specified in all sources—proof required[8]. - Be unable to afford the medication after exhausting other assistance options[6][8]. **Important exclusions**: Commercially insured patients (e.g., employer or FEHB plans) are not eligible. Medicare patients may qualify under specific conditions[2][3][6]. ## Income Eligibility Breakdown The program uses **pre-tax household income** limits at approximately **500% of the FPL**. Specific dollar amounts vary by household size and year; check current FPL guidelines at application. Provide proof like tax returns, W-2s, or pay stubs[4][8]. | Household Size | Approximate Annual Income Limit (500% FPL, 2026 est.) | Notes | |---------------|-------------------------------------------------------|-------| | 1 (Individual) | ~$75,300 | Based on 2025 FPL projections; verify at application[8] | | 2 (Couple) | ~$102,000 | Add ~$26,700 per additional member[8] | | 3 | ~$128,700 | Proof of all household income required[4] | | 4 | ~$155,400 | Includes SSI, pensions, etc.[4] | *Notes*: Exact limits subject to change; program confirms via documents. Electronic verification optional[2][4]. ## Insurance Requirements This program is **primarily for uninsured or underinsured patients**. **Commercially insured patients are ineligible**[2][3][10]. - **Medicare Part D/Advantage**: Possible if enrolled in Medicare Prescription Payment Plan, unable to afford costs post-prior authorization, and meet income rules. Submit Medicare ID and plan details[6][8]. - **Government insurance** (e.g., Medicaid): May qualify if underinsured and costs unaffordable[3][6]. - Submit front/back of insurance cards if applicable. Exhaust co-pay help first[8]. ## Step-by-Step Application Process 1. **Visit Pfizer RxPathways**: Go to www.PfizerRxPathways.com, use the Program Finder, enter "LITFULO," and follow instructions[1][3]. 2. **Choose Method**: Online via **Pfizer PAP Connect** (upload docs, track status) or download/mail/fax form[1][5]. 3. **Complete Enrollment Form**: Patient fills personal/income sections; doctor completes prescription/diagnosis[4][10]. 4. **Gather Documents**: - Proof of income (e.g., 1040 pages 1-2, W-2, 2 pay stubs, SSA-1099)[2][4]. - Prescription and insurance cards (if any)[8]. - HIPAA release (retain copy)[4]. 5. **Submit**: Mail to P.O. Box 66585, St. Louis, MO 63166-6585; fax 866-470-1748 or 1-877-548-1734; or upload online. Call **(833) 956-3376** for help[4][10]. 6. **Sign Certifications**: Affirm inability to pay, authorize verification[2][10]. Applications accepted multiple ways; all pages required[1]. ## Timeline and Delivery Expect notification in **2-3 weeks** (sometimes 3 business days online)[1][4][9]. If approved, receive enrollment letter with term details (reauthorization needed)[1][4]. Medication **ships directly to patient**—free for eligible[program details]. Track via PAP Connect[5]. ## Alternatives if Denied or Ineligible - **Pfizer Dermatology Patient Access**: Co-pay help for commercial insurance[2]. - **State programs**, Medicaid, or marketplace exchanges[3]. - **Manufacturer savings cards** or 340B clinics. - **Reapply** with updated docs or appeal denial. - **Biosimilars**: None available for LITFULO[program details]. - Contact Pfizer at (833) 956-3376 for guidance[program details]. ## Reauthorization **Reauthorization required**—submit new form/docs before refill to confirm ongoing eligibility[program details][1]. ## Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility rules change; always verify at PfizerRxPathways.com or by calling (833) 956-3376. Not medical/financial advice—consult your doctor and advisor. Pfizer may update criteria without notice. Free medicine via Pfizer Inc. and Foundation[4][8]. (Word count: 1028)

Program information last verified: March 30, 2026